Replies to post #940 on Bristol Myers Squibb (BMY)

[DewDiligence]

BMY 3Q20 results—raises_2020_EPS guidance:

https://news.bms.com/news/corporate-financial/2020/Bristol-Myers-Squibb-Reports-Third-Quarter-2020-Financial-Results/default.aspx

2020 non-GAAP EPS guidance is raised to $6.25-63.5 (from the prior range of $6.10-6.25).

2021 non-GAAP EPS guidance remains $7.15-7.45.